High-Yield Dividend Stocks for the Long Haul: Realty Income, Healthpeak Properties, and Pfizer

Realty Income, Healthpeak Properties, and Pfizer are high-yield dividend stocks with yields above 5% and growing cash flows. Realty Income has paid dividends monthly for over 30 years and has a portfolio of 15,606 properties. Healthpeak Properties rents laboratory space to pharmaceutical businesses and biotech start-ups and offers a 6.8% dividend yield. Pfizer is a pharmaceutical company with a 4.3% dividend yield.

Realty Income, Healthpeak Properties, and Pfizer are notable high-yield dividend stocks that have consistently demonstrated strong cash flow growth and attractive dividend yields. Each company offers unique investment opportunities for income-focused investors.

Realty Income (O)
Realty Income, a retail REIT, has a long-standing record of monthly dividend payments, dating back over 30 years. As of September 2025, the company's dividend yield stands at 5.43%, well above the S&P 500 average [2]. Realty Income's portfolio consists of 15,606 properties, providing a diversified revenue stream from retail tenants. The company's financial strength and steady cash flows support its high dividend yield and ongoing dividend growth.

Healthpeak Properties (DOC)
Healthpeak Properties is a healthcare REIT that specializes in renting laboratory space to pharmaceutical businesses and biotech start-ups. The company offers a 6.21% dividend yield as of September 2025 [2]. Healthpeak's portfolio includes 255 properties, with a strong focus on life sciences and healthcare facilities. The company's high dividend yield is supported by its stable rental income and strong financial position.

Pfizer (PFE)
Pfizer, a global biopharmaceutical company, offers a 4.3% dividend yield as of September 2025 [2]. Pfizer's dividend yield is lower than that of Realty Income and Healthpeak Properties but still attractive compared to the S&P 500 average. The company's dividend growth is supported by its strong cash flows and consistent earnings growth. Pfizer's portfolio includes a diverse range of pharmaceutical products, providing a stable revenue stream for dividend payments.

These high-yield dividend stocks offer attractive income opportunities for investors seeking consistent dividend growth and strong cash flows. However, investors should always conduct thorough research and consider their individual financial circumstances before making investment decisions.

References:
[1] https://www.morningstar.com/stocks/3-dividend-stocks-september-2025-2
[2] https://www.fool.com/investing/stock-market/types-of-stocks/dividend-stocks/high-yield-dividend-stocks/